Proteolysis-targeting chimeras (PROTACs) and molecular glue degraders (MGDs) are probably the most maturely developed TPD approaches. During this overview, we focus on equally preclinical experiments and scientific trials to provide an extensive summary of the security and scientific usefulness of PROTACs and MGDs in hematologic malignancies in the last twenty https://cruzjpvzd.verybigblog.com/31136375/the-smart-trick-of-dorsomorphin-that-no-one-is-discussing